An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks

N Hofer, E Zacharias, W Müller, B Resch - Neonatology, 2012 - karger.com
C-reactive protein (CRP) is one of the most studied and most used laboratory tests for
neonatal sepsis. As part of the acute-phase reaction to infection, it plays a central role in the …

[HTML][HTML] Diagnosis of neonatal sepsis: the role of inflammatory markers

J Eichberger, E Resch, B Resch - Frontiers in Pediatrics, 2022 - frontiersin.org
This is a narrative review on the role of biomarkers in the diagnosis of neonatal sepsis. We
describe the difficulties to obtain standardized definitions in neonatal sepsis and discuss the …

[HTML][HTML] Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review

S Kurath, G Halwachs-Baumann, W Müller… - Clinical Microbiology and …, 2010 - Elsevier
To analyse current data on transmission of human cytomegalovirus (HCMV) via breast milk
with subsequent symptomatic HCMV infection of the preterm infant and to report on long …

[HTML][HTML] Suppl 2: risk factors for severe respiratory syncytial virus lower respiratory tract infection

C Sommer, B Resch, EAF Simões - The open microbiology journal, 2011 - ncbi.nlm.nih.gov
RSV infection is a leading cause of lower respiratory tract infection, especially in High-risk
infants with a history of prematurity, bronchopulmonary dysplasia (BPD), congenital heart …

Risk factors and determinants of neurodevelopmental outcome in cystic periventricular leucomalacia

B Resch, E Vollaard, U Maurer, J Haas… - European journal of …, 2000 - Springer
The aim of the study was to determine risk factors for the development of cystic
periventricular leucomalacia (PVL) and to correlate ultrasound findings with …

Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection

B Resch - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
Respiratory syncytial virus (RSV) accounts for about 20% of all respiratory infections in
children below the age of 5 y. It is associated with up to 63% of all acute respiratory …

The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates

N Hofer, R Kothari, N Morris, W Müller… - American journal of …, 2013 - Elsevier
Objective The aim of this study was to show and discuss an association between fetal
inflammatory response syndrome (FIRS) and an adverse neonatal outcome defined as …

Expert consensus on palivizumab use for respiratory syncytial virus in developed countries

MS Luna, P Manzoni, B Paes, E Baraldi… - Paediatric respiratory …, 2020 - Elsevier
Respiratory syncytial virus (RSV) infection is a leading cause of hospitalisation in early
childhood and palivizumab is the only licensed intervention for prevention. Palivizumab …

Fetal and early neonatal interleukin-6 response

C Chiesa, L Pacifico, F Natale, N Hofer, JF Osborn… - Cytokine, 2015 - Elsevier
In 1998, a systemic fetal cytokine response, defined as a plasma interleukin-6 (IL-6) value
above 11 pg/mL, was reported to be a major independent risk factor for the subsequent …

Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life

N Hofer, W Müller, B Resch - Clinical chemistry and laboratory …, 2011 - degruyter.com
Background: Our aim was to analyze C-reactive protein (CRP) values in term and preterm
infants and correlate non-infection-associated increases with various neonatal disorders …